American College of Chest Physicians,
Mesenchymal stem cells may be safe in pulmonary fibrosis. #journalCHEST
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER) A Phase I Safety Clinical Trial
Overview of attention for article published in CHEST, November 2016
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
Good Attention Score compared to outputs of the same age and source (74th percentile)
Readers on
- mendeley
- 211 Mendeley